# Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients

> **NCT02062983** · — · SUSPENDED · sponsor: **National Guard Health Affairs** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Herceptin

## Key facts

- **NCT ID:** NCT02062983
- **Lead sponsor:** National Guard Health Affairs
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Difficulty in enrolling patients
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062983, "Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02062983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*